SE0104333D0 - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- SE0104333D0 SE0104333D0 SE0104333A SE0104333A SE0104333D0 SE 0104333 D0 SE0104333 D0 SE 0104333D0 SE 0104333 A SE0104333 A SE 0104333A SE 0104333 A SE0104333 A SE 0104333A SE 0104333 D0 SE0104333 D0 SE 0104333D0
- Authority
- SE
- Sweden
- Prior art keywords
- sup
- well
- therapeutic agents
- racemates
- prodrugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Priority Applications (28)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0104333A SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Therapeutic agents |
HU0402093A HUP0402093A3 (en) | 2001-12-19 | 2002-12-18 | 3-phenyl-2-phenethylthio-propionic acid derivatives as selective agonists of ppar-alpha, their preparation and pharmaceutical compositions containing them |
IL16237802A IL162378A0 (en) | 2001-12-19 | 2002-12-18 | 3-Phenyl-2-arylalkylthiopropionic acid derivativesas selective agonists of ppar-al-pha |
CNB028281225A CN100343229C (zh) | 2001-12-19 | 2002-12-18 | 作为选择性PPAR-α激动剂的3-苯基-2-芳基烷基硫代丙酸衍生物 |
US10/499,042 US7276539B2 (en) | 2001-12-19 | 2002-12-18 | 3-Phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
NZ533365A NZ533365A (en) | 2001-12-19 | 2002-12-18 | 3-Phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
EP02788144A EP1458677B1 (en) | 2001-12-19 | 2002-12-18 | 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
TW091136517A TW200410678A (en) | 2001-12-19 | 2002-12-18 | Therapeutic agents |
AT02788144T ATE428691T1 (de) | 2001-12-19 | 2002-12-18 | 3-phenyl-2-arylalkylthiopropionsäure-derivate als selektive agonisten von ppar-alpha |
PCT/GB2002/005743 WO2003051826A1 (en) | 2001-12-19 | 2002-12-18 | 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
DE60232018T DE60232018D1 (de) | 2001-12-19 | 2002-12-18 | 3-phenyl-2-arylalkylthiopropionsäure-derivate als selektive agonisten von ppar-alpha |
MXPA04005992A MXPA04005992A (es) | 2001-12-19 | 2002-12-18 | Derivados de acido 3-fenil-2-arilalquiltiopropionico como antagonistas selectivos de ppar-alfa. |
CA002470066A CA2470066C (en) | 2001-12-19 | 2002-12-18 | 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
PL02370623A PL370623A1 (en) | 2001-12-19 | 2002-12-18 | 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
AU2002352426A AU2002352426A1 (en) | 2001-12-19 | 2002-12-18 | 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
UA20040604534A UA80407C2 (en) | 2001-12-19 | 2002-12-18 | 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of parp-alpha |
RU2004117776/04A RU2004117776A (ru) | 2001-12-19 | 2002-12-18 | Производные 3-фенил-2-арилалкилтиопропионовой кислоты в качестве селективных антагонистов ppar-альфа |
JP2003552714A JP3810770B2 (ja) | 2001-12-19 | 2002-12-18 | PPARαの選択的アンタゴニストとしての3−フェニル−2−アリールアルキルチオプロピオン酸誘導体 |
KR10-2004-7009348A KR20040068589A (ko) | 2001-12-19 | 2002-12-18 | Ppar-알파의 선택적 효능제로서3-페닐-2-아릴알킬티오프로피온산 유도체 |
BR0215090-5A BR0215090A (pt) | 2001-12-19 | 2002-12-18 | Composto, enanciÈmero (r) ou enanciÈmero (s) de um composto, formulação farmacêutica, método para tratar ou prevenir distúrbios lipìdicos (dislipidemia) associados ou não com resistência à insulina, uso de um composto, método para tratar ou prevenir diabetes de tipo 2, processo para preparar um composto, e, composição farmacêutica |
ES02788144T ES2324025T3 (es) | 2001-12-19 | 2002-12-18 | Derivados del acido 3-fenil-2-arilalquiltiopropionico como agonistas selectivos de ppar-alfa. |
ARP020105003A AR038046A1 (es) | 2001-12-19 | 2002-12-19 | Derivados de acidos 3-fenil-2-arilalquiltiopropionicos moduladores de ppar alfa |
IS7303A IS7303A (is) | 2001-12-19 | 2004-06-08 | 3-fenýl-2-arýlalkýlþíóprópíónsýruafleiður sem valvís gerandefni PPAR-ALFA |
ZA200404585A ZA200404585B (en) | 2001-12-19 | 2004-06-09 | 3-Phenyl-2-arylalkylthiopropionic acid derivativesas selective agonists of PPAR-alpha. |
CO04068143A CO5590908A2 (es) | 2001-12-19 | 2004-07-16 | Derivados de acido 3-fenil-2-arilalquiltiopropionico como antagonistas selectivos de ppar-alfa |
NO20043084A NO20043084L (no) | 2001-12-19 | 2004-07-16 | 3-fenyl-2-arylalkyltiopropionsyre derivater som selektive agnoister av PPAR-ALPHA |
HK05100665.9A HK1068866A1 (en) | 2001-12-19 | 2005-01-25 | 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
JP2006077296A JP2006241162A (ja) | 2001-12-19 | 2006-03-20 | PPARαの選択的アンタゴニストとしての3−フェニル−2−アリールアルキルチオプロピオン酸誘導体 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0104333A SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0104333D0 true SE0104333D0 (sv) | 2001-12-19 |
Family
ID=20286432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0104333A SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Therapeutic agents |
Country Status (27)
Country | Link |
---|---|
US (1) | US7276539B2 (sv) |
EP (1) | EP1458677B1 (sv) |
JP (2) | JP3810770B2 (sv) |
KR (1) | KR20040068589A (sv) |
CN (1) | CN100343229C (sv) |
AR (1) | AR038046A1 (sv) |
AT (1) | ATE428691T1 (sv) |
AU (1) | AU2002352426A1 (sv) |
BR (1) | BR0215090A (sv) |
CA (1) | CA2470066C (sv) |
CO (1) | CO5590908A2 (sv) |
DE (1) | DE60232018D1 (sv) |
ES (1) | ES2324025T3 (sv) |
HK (1) | HK1068866A1 (sv) |
HU (1) | HUP0402093A3 (sv) |
IL (1) | IL162378A0 (sv) |
IS (1) | IS7303A (sv) |
MX (1) | MXPA04005992A (sv) |
NO (1) | NO20043084L (sv) |
NZ (1) | NZ533365A (sv) |
PL (1) | PL370623A1 (sv) |
RU (1) | RU2004117776A (sv) |
SE (1) | SE0104333D0 (sv) |
TW (1) | TW200410678A (sv) |
UA (1) | UA80407C2 (sv) |
WO (1) | WO2003051826A1 (sv) |
ZA (1) | ZA200404585B (sv) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0311932A (pt) | 2002-06-20 | 2005-03-22 | Astrazeneca Ab | Composto, formulação farmacêutica, método para tratar ou prevenir resistência à insulina, uso de um composto, processo para preparar um composto, e, tratamento combinado |
GB0314130D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0314131D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0314075D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0314134D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0314260D0 (en) | 2003-06-19 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0427524D0 (en) * | 2004-12-16 | 2005-01-19 | Astrazeneca Ab | Chemical process |
GB0427701D0 (en) * | 2004-12-17 | 2005-01-19 | Astrazeneca Ab | Therapeutic agents |
ES2445049T3 (es) | 2007-03-08 | 2014-02-27 | Albireo Ab | Derivados del ácido 3-fenilpropiónico y su uso en el tratamiento de la enfermedad inflamatoria intestinal |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
US5232945A (en) * | 1992-07-20 | 1993-08-03 | Pfizer Inc. | 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives |
AU1903799A (en) | 1997-12-05 | 1999-06-28 | Eisai Co. Ltd. | Compositions and methods for modulating the activity of fibroblast growth factor |
EP1067109B1 (en) * | 1998-03-10 | 2009-12-09 | Ono Pharmaceutical Co., Ltd. | Carboxylic acid derivatives and drugs containing the same as the active ingredient |
MA26634A1 (fr) * | 1998-06-04 | 2004-12-20 | Astra Ab | Nouveaux derives de l'acide 3-aryl propionique et analogues |
SE9801992D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
SE9801990D0 (sv) | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl propionic acid derivatives and analogs |
GB9822473D0 (en) * | 1998-10-16 | 1998-12-09 | Glaxo Group Ltd | Chemical compounds |
EE200100556A (et) | 1999-04-28 | 2003-02-17 | Aventis Pharma Deutschland Gmbh | Diarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi kasutamine ravimite valmistamiseks |
TWI262185B (en) | 1999-10-01 | 2006-09-21 | Eisai Co Ltd | Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives |
TW574193B (en) | 1999-12-03 | 2004-02-01 | Astrazeneca Ab | Novel phenalkyloxy-phenyl derivatives, pharmaceutical composition containing the same and their uses |
SE9904421D0 (sv) | 1999-12-03 | 1999-12-03 | Astra Ab | New compounds |
SE0000772D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | Chemical compounds |
KR20020081424A (ko) | 2000-03-09 | 2002-10-26 | 아벤티스 파마 도이칠란트 게엠베하 | Ppar 매개인자의 치료학적 용도 |
SE0003766D0 (sv) | 2000-10-18 | 2000-10-18 | Astrazeneca Ab | Novel formulation |
EG26979A (en) | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
TWI311133B (en) * | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
SE0101978D0 (sv) | 2001-06-01 | 2001-06-01 | Astrazeneca Ab | New compounds |
GB0121337D0 (en) | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
GB0121621D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
IL160691A0 (en) | 2001-09-08 | 2004-08-31 | Astrazeneca Ab | Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment of hyperlipidaemia |
SE0104334D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
GB0229931D0 (en) | 2002-12-21 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
SE0201937D0 (sv) | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | Therapeutic agents |
BR0311932A (pt) | 2002-06-20 | 2005-03-22 | Astrazeneca Ab | Composto, formulação farmacêutica, método para tratar ou prevenir resistência à insulina, uso de um composto, processo para preparar um composto, e, tratamento combinado |
SE0201936D0 (sv) | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | Therapeutic agents |
GB0314075D0 (en) | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0314136D0 (en) | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0314129D0 (en) | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0314078D0 (en) | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0314130D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0314131D0 (en) | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0314260D0 (en) | 2003-06-19 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
-
2001
- 2001-12-19 SE SE0104333A patent/SE0104333D0/sv unknown
-
2002
- 2002-12-18 AT AT02788144T patent/ATE428691T1/de not_active IP Right Cessation
- 2002-12-18 TW TW091136517A patent/TW200410678A/zh unknown
- 2002-12-18 EP EP02788144A patent/EP1458677B1/en not_active Expired - Lifetime
- 2002-12-18 WO PCT/GB2002/005743 patent/WO2003051826A1/en active Application Filing
- 2002-12-18 DE DE60232018T patent/DE60232018D1/de not_active Expired - Lifetime
- 2002-12-18 CN CNB028281225A patent/CN100343229C/zh not_active Expired - Fee Related
- 2002-12-18 AU AU2002352426A patent/AU2002352426A1/en not_active Abandoned
- 2002-12-18 PL PL02370623A patent/PL370623A1/xx unknown
- 2002-12-18 CA CA002470066A patent/CA2470066C/en not_active Expired - Fee Related
- 2002-12-18 JP JP2003552714A patent/JP3810770B2/ja not_active Expired - Fee Related
- 2002-12-18 IL IL16237802A patent/IL162378A0/xx unknown
- 2002-12-18 NZ NZ533365A patent/NZ533365A/en unknown
- 2002-12-18 RU RU2004117776/04A patent/RU2004117776A/ru not_active Application Discontinuation
- 2002-12-18 BR BR0215090-5A patent/BR0215090A/pt not_active IP Right Cessation
- 2002-12-18 MX MXPA04005992A patent/MXPA04005992A/es not_active Application Discontinuation
- 2002-12-18 KR KR10-2004-7009348A patent/KR20040068589A/ko not_active Application Discontinuation
- 2002-12-18 HU HU0402093A patent/HUP0402093A3/hu unknown
- 2002-12-18 ES ES02788144T patent/ES2324025T3/es not_active Expired - Lifetime
- 2002-12-18 US US10/499,042 patent/US7276539B2/en not_active Expired - Fee Related
- 2002-12-18 UA UA20040604534A patent/UA80407C2/uk unknown
- 2002-12-19 AR ARP020105003A patent/AR038046A1/es not_active Application Discontinuation
-
2004
- 2004-06-08 IS IS7303A patent/IS7303A/is unknown
- 2004-06-09 ZA ZA200404585A patent/ZA200404585B/en unknown
- 2004-07-16 CO CO04068143A patent/CO5590908A2/es not_active Application Discontinuation
- 2004-07-16 NO NO20043084A patent/NO20043084L/no not_active Application Discontinuation
-
2005
- 2005-01-25 HK HK05100665.9A patent/HK1068866A1/xx not_active IP Right Cessation
-
2006
- 2006-03-20 JP JP2006077296A patent/JP2006241162A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
ATE428691T1 (de) | 2009-05-15 |
CA2470066A1 (en) | 2003-06-26 |
RU2004117776A (ru) | 2006-01-10 |
KR20040068589A (ko) | 2004-07-31 |
HUP0402093A3 (en) | 2008-08-28 |
NO20043084L (no) | 2004-07-16 |
CA2470066C (en) | 2007-04-10 |
EP1458677B1 (en) | 2009-04-15 |
JP3810770B2 (ja) | 2006-08-16 |
US20050215630A1 (en) | 2005-09-29 |
PL370623A1 (en) | 2005-05-30 |
ZA200404585B (en) | 2005-10-26 |
US7276539B2 (en) | 2007-10-02 |
JP2005511785A (ja) | 2005-04-28 |
DE60232018D1 (de) | 2009-05-28 |
CN100343229C (zh) | 2007-10-17 |
AU2002352426A1 (en) | 2003-06-30 |
ES2324025T3 (es) | 2009-07-29 |
TW200410678A (en) | 2004-07-01 |
AR038046A1 (es) | 2004-12-22 |
MXPA04005992A (es) | 2004-09-27 |
CO5590908A2 (es) | 2005-12-30 |
WO2003051826A1 (en) | 2003-06-26 |
UA80407C2 (en) | 2007-09-25 |
HUP0402093A2 (hu) | 2005-02-28 |
IS7303A (is) | 2004-06-08 |
IL162378A0 (en) | 2005-11-20 |
EP1458677A1 (en) | 2004-09-22 |
JP2006241162A (ja) | 2006-09-14 |
BR0215090A (pt) | 2004-11-16 |
HK1068866A1 (en) | 2005-05-06 |
NZ533365A (en) | 2006-05-26 |
CN1620430A (zh) | 2005-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0104334D0 (sv) | Therapeutic agents | |
TW200508180A (en) | Therapeutic agents | |
SE0302487D0 (sv) | Novel compounds | |
CO5271691A1 (es) | Nuevos compuestos | |
HK1089163A1 (en) | Quinoxaline derivatives as neutrophil elastase inhibitors and their use | |
DE60315674D1 (de) | Neue imidazopyridine und ihre verwendung | |
SE9904176D0 (sv) | New use | |
MY137156A (en) | Dual nk1/nk3 derivatives | |
SE0202463D0 (sv) | Novel compounds | |
SE0302323D0 (sv) | Novel compounds | |
UA66852C2 (uk) | Похідні та аналоги 3-арилпропіонової кислоти, спосіб їх отримання, фармацевтична композиція (варіанти) та спосіб профілактики та/або лікування асоційованих з резистентністю до інсуліну клінічних станів | |
BR0313407A (pt) | Novo uso de derivados de benzotiazol | |
SE9903997D0 (sv) | New compounds | |
SE0104333D0 (sv) | Therapeutic agents | |
SE0302756D0 (sv) | Novel Compounds | |
IL166103A0 (en) | Pyrrolidine derivatives and their use | |
SE0102057D0 (sv) | New Salts I | |
SE0102058D0 (sv) | New Salts II | |
DK0556813T3 (da) | Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler | |
DE60103034D1 (de) | Neue phenylheteroalkylamin-derivate | |
SE0201936D0 (sv) | Therapeutic agents | |
SE0102640D0 (sv) | Novel compounds | |
TW200502202A (en) | Therapeutic agents | |
SE9901530D0 (sv) | Novel compounds | |
SE0201935D0 (sv) | Therapeutic agents |